-Carlos H Serezani Researcher Activity Profile

Research Author Detailed Information 

Carlos H Serezani Publication Rate By Year

Carlos H Serezani has published 12 paper(s) in 2007, 1 paper(s) in 2008, for a total of 13 research publications in total.

Carlos H Ch Serezani Author Information

LAST NAME: serezani

FIRST NAME: Carlos H

INITIALS: ch

AFFILIATION:

Papers

Carlos H Serezani's Publication Record

1. Synthetic prostacyclin analogs differentially regulate macrophage function via distinct analog-receptor binding specificities. Year Published: 2007
Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Health Systems, Ann Arbor, MI 48109, USA. daronoff@umich.edu
2. Specific leukotriene receptors couple to distinct G proteins to effect stimulation of alveolar macrophage host defense functions. Year Published: 2007
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI 48109, USA.
3. Prostaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase. Year Published: 2007
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Health Systems, Ann Arbor, Michigan 48109-0642, USA.
4. Leukotrienes: mediators that have been typecast as villains. Year Published: 2007
Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
5. NADPH oxidase deficiency results in reduced alveolar macrophage 5-lipoxygenase expression and decreased leukotriene synthesis. Year Published: 2007
University of Michigan Medical Center, 6301 MSRBIII, 1150 W. Medical Center Dr., Ann Arbor, MI 48109-0642, USA. coffeym@umich.edu.
6. Activation of Phosphatase and Tensin Homolog on Chromosome 10 Mediates the Inhibition of Fc{gamma}R Phagocytosis by Prostaglandin E2 in Alveolar Macrophages. Year Published: 2007
Division of Pulmonary and Critical Care Medicine and.
7. Effects of prostaglandin E(2) on the subcellular localization of Epac-1 and Rap1 proteins during Fcgamma-receptor-mediated phagocytosis in alveolar macrophages. Year Published: 2007
Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, The University of Michigan Health System, Ann Arbor, MI 48109, USA.
8. Leukotrienes: mediators that have been typecast as villains. Year Published: 2007
Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
9. NADPH oxidase deficiency results in reduced alveolar macrophage 5-lipoxygenase expression and decreased leukotriene synthesis. Year Published: 2007
Division of Pulmonary and Critical Care Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109-0642, USA. coffeym@umich.edu
10. Activation of phosphatase and tensin homolog on chromosome 10 mediates the inhibition of FcgammaR phagocytosis by prostaglandin E2 in alveolar macrophages. Year Published: 2007
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Health System, Ann Arbor 48109, USA.
11. NADPH oxidase deficiency results in reduced alveolar macrophage 5-lipoxygenase expression and decreased leukotriene synthesis. Year Published: 2007
Division of Pulmonary and Critical Care Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109-0642, USA. coffeym@umich.edu
12. Effects of prostaglandin E2 on the subcellular localization of Epac-1 and Rap1 proteins during Fcgamma-receptor-mediated phagocytosis in alveolar macrophages. Year Published: 2007
Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, The University of Michigan Health System, Ann Arbor, MI 48109, USA.
13. Stimulatory Effects of Peroxisome Proliferator-Activated Receptor-gamma on Fcgamma Receptor-Mediated Phagocytosis by Alveolar Macrophages. Year Published: 2008
Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Health System, Ann Arbor 48109, MI, USA.